STRATEGIES FOR VACCINE DEVELOPMENT OF COVID-19 IN THE WORLD

Mirkhamidova Sevara Mirmakhmudovna; Abrarul Haq; Ilyasova Munisa Mirvaliyevna; Khudaykulova Gulnara Karimovna

doi:10.37547/ijmscr/Volume03Issue03-02

Articles | Open Access

STRATEGIES FOR VACCINE DEVELOPMENT OF COVID-19 IN THE WORLD

Issue: Vol. 3 No. 03 (2023): Volume03 Issue03 | Pages: 5-19 | Crossref DOI: https://doi.org/10.37547/ijmscr/Volume03Issue03-02
Published Date: 2023-03-11

Authors

Mirkhamidova Sevara Mirmakhmudovna
Assitant Of The Department Of Public Health And Management, Tashkent Medical Academy, Uzbekistan
Abrarul Haq
Student Of International Faculty, Tashkent Medical Academy, Uzbekistan
Ilyasova Munisa Mirvaliyevna
Assistant (Phd) Of The Department Of Public Health And Management, Tashkent Medical Academy, Uzbekistan
Khudaykulova Gulnara Karimovna
Associate Professor (Dsc) Of The Department Of Public Health And Management, Tashkent Medical Academy, Uzbekistan

Google Scholar
Views: 40 Downloads: 20
Download PDF: PDF

Share This Article

How to Cite

Mirkhamidova Sevara Mirmakhmudovna, Abrarul Haq, Ilyasova Munisa Mirvaliyevna, & Khudaykulova Gulnara Karimovna. (2023). STRATEGIES FOR VACCINE DEVELOPMENT OF COVID-19 IN THE WORLD. International Journal of Medical Sciences And Clinical Research, 3(03), 5–19. https://doi.org/10.37547/ijmscr/Volume03Issue03-02

More Citation Formats

Download Citation

Abstract

The purpose of this phase is to study the best doses to use, the most common side effects and how many doses are needed and protect individuals at highest risk from serious illness or death.

Keywords:

Antibody, antibody-dependent enhancement, mucosal immunization

References

Sheng Wu Gong Cheng Xue Bao

Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther. 2022 May 3;7(1):146. doi: 10.1038/s41392-022-00996-y. PMID: 35504917; PMCID: PMC9062866. https://pubmed.ncbi.nlm.nih.gov/35504917/

Zhang Z, Mateus J, Coelho CH, Dan JM, Moderbacher CR, Gálvez RI, Cortes FH, Grifoni A, Tarke A, Chang J, Escarrega EA, Kim C, Goodwin B, Bloom NI, Frazier A, Weiskopf D, Sette A, Crotty S. Humoral and cellular immune memory to four COVID-19 vaccines. Cell. 2022 Jul 7;185(14):2434-2451.e17. doi: 10.1016/j.cell.2022.05.022. Epub 2022 May 27. PMID: 35764089; PMCID: PMC9135677. ttps://pubmed.ncbi.nlm.nih.gov/35271316/

Upreti S, Samant M. A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens. Pharm Res. 2022 Sep;39(9):2119-2134. doi: 10.1007/s11095-022-03323-w. Epub 2022 Jul 1. PMID: 35773445; PMCID: PMC9247891. https://pubmed.ncbi.nlm.nih.gov/35768142/

Zhou Z, Zhu Y, Chu M. Role of COVID-19 Vaccines in SARS-CoV-2 Variants. Front Immunol. 2022 May 20;13:898192. doi: 10.3389/fimmu.2022.898192. PMID: 35669787; PMCID: PMC9165056. https://pubmed.ncbi.nlm.nih.gov/35737293/

Wang J, Zhang Q, Wang H, Gong W. The Potential Roles of BCG Vaccine in the Prevention or Treatment of COVID-19. Front Biosci (Landmark Ed). 2022 May 13;27(5):157. doi: 10.31083/j.fbl2705157. PMID: 35638424. https://pubmed.ncbi.nlm.nih.gov/35229416

Brillo E, Tosto V, Gerli S, Buonomo E. COVID-19 vaccination in pregnancy and postpartum. J Matern Fetal Neonatal Med. 2022 Dec;35(25):6727-6746. doi: 10.1080/14767058.2021.1920916. Epub 2021 May 16. PMID: 33998379. https://pubmed.ncbi.nlm.nih.gov/33998379/

Vorster L, Kirk SE, Muscal E, Despotovic JM, Cohen CT, Sartain SE. COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents. Pediatr Blood Cancer. 2022 Jun;69(6):e29681. doi: 10.1002/pbc.29681. Epub 2022 Apr 4. PMID: 35373880; PMCID: PMC9088367. https://pubmed.ncbi.nlm.nih.gov/35373880/

Gautam A, Bhattarai U. Misuse of Antipyretic Amid Fear of COVID-19 Vaccine. JNMA J Nepal Med Assoc. 2022 Mar 11;60(247):329-330. doi: 10.31729/jnma.6262. PMID: 35633272; PMCID: PMC9226747. https://pubmed.ncbi.nlm.nih.gov/35633272/

Fansher M, Adkins TJ, Lalwani P, Boduroglu A, Carlson M, Quirk M, Lewis RL, Shah P, Zhang H, Jonides J. Icon arrays reduce concern over COVID-19 vaccine side effects: a randomized control study. Cogn Res Princ Implic. 2022 May 7;7(1):38. doi: 10.1186/s41235-022-00387-5. PMID: 35524896; PMCID: PMC9077983. https://pubmed.ncbi.nlm.nih.gov/35524896/

Lee SJ, Park DW, Sohn JW, Yoon HJ, Kim SH. COVID-19 Vaccine-Induced Multisystem Inflammatory Syndrome With Polyserositis Detected by FDG PET/CT. Clin Nucl Med. 2022 May 1;47(5):e397-e398. doi: 10.1097/RLU.0000000000004094. PMID: 35175945; PMCID: PMC8983611. https://pubmed.ncbi.nlm.nih.gov/35175945/

Hilts A, Schreiber A, Singh A. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome. Am J Case Rep. 2022 Aug 10;23:e936896. doi: 10.12659/AJCR.936896. PMID: 35945825; PMCID: PMC9377719. https://pubmed.ncbi.nlm.nih.gov/35945825/

Mori M, Yokoyama A, Shichida A, Sasuga K, Maekawa T, Moriyama T. Impact of Sex and Age on mRNA COVID-19 Vaccine-Related Side Effects in Japan. Microbiol Spectr. 2022 Dec 21;10(6):e0130922. doi: 10.1128/spectrum.01309-22. Epub 2022 Oct 31. PMID: 36314943; PMCID: PMC9769945. https://pubmed.ncbi.nlm.nih.gov/36314943/

Renemane L, Vrublevska J, Cera I. First Episode Psychosis Following COVID-19 Vaccination: a Case Report. Psychiatr Danub. 2022 Sep;34(Suppl 8):56-59. PMID: 36170703. https://pubmed.ncbi.nlm.nih.gov/36170703/

Махсумов М. Д. и др. Impact of COVID-19 on education system in the world and in Uzbekistan //Образование: прошлое, настоящее и будущее. – 2020. – С. 94-95.

Most read articles by the same author(s)

Mirkhamidova Sevara Mirmakhmudovna, Jenifer Alat Stephen, Karimbayev Shakhrambay Dexkanbayevich, Abdurashitova Sharafat Abdumajidovna, IMPLEMENTATION AND RESULTS OF SURVEY HELD IN THE AWARENESS OF PUBLIC ON ALLERGIC CONTACT DERMATITIS , International Journal of Medical Sciences And Clinical Research: Vol. 3 No. 03 (2023): Volume03 Issue03